Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | What Analysts Are Saying About Alignment Healthcare Stock | 1 | Benzinga.com | ||
Fr | Alignment Healthcare behält hohe CMS-Sternebewertung, Analyst bleibt optimistisch | 2 | Investing.com Deutsch | ||
Fr | Alignment Healthcare Continues to Deliver High-Quality Medicare Advantage Plans, 4 Stars or Greater for 98% of Members in 2025 | 1 | GlobeNewswire (USA) | ||
Fr | CVS, Alignment Healthcare big winners from Medicare quality ratings, Stephens says | 8 | Reuters | ||
Fr | KeyBanc initiates coverage on Alignment Healthcare with Sector Weight rating | 1 | Investing.com | ||
Do | Alignment HealthCare Partners With Intermountain Health in Nevada | 2 | Zacks | ||
Di | Alignment Healthcare target raised to $14 on CMS star rating | 1 | Investing.com | ||
03.10. | Alignment Healthcare USA, LLC: Alignment Health Plan Expands Provider Network with Intermountain Health, Enhancing Care Access in Nevada | 1 | GlobeNewswire (USA) | ||
01.10. | Alignment Healthcare USA, LLC: Alignment Health Plan Introduces 2025 Medicare Advantage Plans to Address Diverse Care Needs of Seniors, from Cost Concerns to Chronic Conditions | 2 | GlobeNewswire (USA) | ||
14.09. | Alignment Healthcare's chief legal officer sells over $330k in stock | 1 | Investing.com | ||
12.09. | Alignment Healthcare predicts membership surge, targeting 1M enrollees | 1 | FierceHealthcare | ||
11.09. | ALHC stock hits 52-week high at $10.18 amid robust annual growth | 2 | Investing.com | ||
06.09. | Alignment Healthcare CFO sells shares worth over $64k | 2 | Investing.com | ||
29.08. | Alignment Healthcare USA, LLC: Alignment Health Plan Ranks No. 2 in Customer Satisfaction Among Medicare Advantage Plans in California in J.D. Power Study | 2 | GlobeNewswire (USA) | ||
28.08. | Alignment Healthcare to Present at Baird Global Healthcare Conference | 2 | GlobeNewswire (USA) | ||
21.08. | Alignment Healthcare USA, LLC: Aging in Place, Lack of Transportation and Access, and Economic Insecurity Are Top Three Social Barriers to U.S. Senior Health | 2 | GlobeNewswire (USA) | ||
16.08. | Alignment Healthcare, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
16.08. | Alignment Healthcare Updates its Board of Directors | 1 | GlobeNewswire (USA) | ||
14.08. | Baird raises Alignment Healthcare stock target on growth outlook | 2 | Investing.com | ||
14.08. | What Analysts Are Saying About Alignment Healthcare Stock | 1 | Benzinga.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
EMEIS | 5,479 | -0,67 % | emeis: Availability of the 2024 Half-Year Financial Report | Regulatory News:
emeis (Paris:EMEIS) filed, today, its half-year financial report for the period starting on 1 January 2024 and ending on 30 June 2024, with the French Autorité des Marchés Financiers... ► Artikel lesen | |
NANO-X IMAGING | 6,015 | +1,26 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
BUTTERFLY NETWORK | 1,805 | +3,44 % | Butterfly Network Inc.: Butterfly Network bringt seine nächste Generation Butterfly iQ3 in Europa auf den Markt | Butterfly iQ3 basiert auf der Ultrasound-on-Chip-Technologie der nächsten Generation, die sich durch eine einzigartige Bildqualität, neue 3D-Bildgebungsfunktionen und ein kompakteres und leichteres... ► Artikel lesen | |
GOODRX | 6,900 | +0,29 % | GoodRx Reports Second Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
JOINT CORP | 10,640 | -0,37 % | The Joint Corp. to Participate in the 7th Annual B. Riley Securities Consumer & TMT Conference | ||
CARMAT | 1,386 | -1,14 % | CARMAT Announces the Completion of Its Capital Increase for a Gross Amount of €10.3 Million (Namely 100% of the Initial Offer) | Continued and significant support from two reference shareholders, for a total amount of €5.5 million Net proceeds of €9.4 million, enabling CARMAT to extend its cash runway until early... ► Artikel lesen | |
HYPERFINE | 1,000 | 0,00 % | Hyperfine, Inc.: Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care | The Swoop® Portable MR Imaging® system shows faster time-to-scan compared to conventional MRI and good specificity in emergency stroke care
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
MIMEDX | 5,710 | +3,63 % | MiMedx-Aktie erreicht 52-Wochen-Tief bei 5,56 US-Dollar | ||
TALKSPACE | 2,450 | +5,60 % | Talkspace Announces Second Quarter 2024 Results | 2Q 2024 Total revenue grew 29% year-over-year, driven by 62%year-over-year growth in Payor revenue Reduced GAAP Net loss to $0.5 million from $4.7 million year-over-year 2Q 2024 Adjusted EBITDA1 of... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 71,70 | -0,84 % | PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer | A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate Cancer Represents Potential Paradigm Shift in... ► Artikel lesen | |
BIOMERICA | 0,331 | +3,05 % | Biomerica, Inc.: Biomerica Reports Fiscal 2024 Year End Results | Total Revenue Increases 1% Year-Over-Year - Core Revenue Excluding COVID Tests Climbs 5%, Reflecting Stronger GrowthSignificant Cost Savings Plan Implemented After Year End - Expected to Deliver Expense... ► Artikel lesen | |
ATRICURE | 27,840 | +2,92 % | AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe | ||
PROGYNY | 16,095 | -2,16 % | Progyny, Inc. Announces Second Quarter 2024 Results | Achieves Record Quarterly Adjusted EBITDA, Strong Cash Flow Conversion RateBoard Authorizes Repurchase of $100 Million of Common Stock NEW YORK, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq:... ► Artikel lesen | |
PROPHASE LABS | 1,970 | -2,48 % | ProPhase Labs, Inc.: ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated | Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database... ► Artikel lesen | |
AMWELL | 10,200 | +0,44 % | Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution | BOSTON and MENLO PARK, Calif., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, today announced Hello Heart, the digital leader in preventive heart health, is a partner... ► Artikel lesen |